Afuco™ Anti-CD276 ADCC Recombinant Antibody, ADCC Enhanced (AFC-TAB-424CQ)

CAT#: AFC-TAB-424CQ

This product is an ADCC enhanced antibody produced by our Afuco™ platform. Recombinant monoclonal antibody to CD276. It is a humanized monoclonal antibody that can be potentially used in the treatment of Solid tumors.

Gene Expression
Figure 1 IF staining of human cell line A-431 Figure 2 Placenta. Figure 3 Testis Figure 4 Cerebral cortex Figure 5 Colon Figure 6 Liver Figure 7 RNA cell line category: Cell line enhanced (HaCaT, U-2197)

Specifications

  • Immunogen
  • The details of the immunogen for this antibody are not available.
  • Host Species
  • Human
  • Derivation
  • Humanized
  • Type
  • ADCC enhanced antibody
  • Specificity
  • Human CD276
  • Species Reactivity
  • Human
  • Applications
  • ELISA, IHC, FC, IP, IF, FuncS
  • Conjugate
  • Unconjugated
  • Generic Name
  • Enoblituzumab
  • Related Disease
  • Solid tumors

Product Property

  • Purity
  • >95% by SDS-PAGE
  • Storage
  • Store at +4°C short term (1-2 weeks). Aliquot and store at -20°C long term. Avoid repeated freeze/thaw cycles.

Target

  • Alternative Names
  • CD276 Molecule; Costimulatory Molecule; CD276 Antigen; B7 Homolog 3; 4Ig-B7-H3; B7-H3; B7H3; B7RP-2
REVIEWS AND Q&AS CITATIONS RESOURCES DOWNLOADS RELATED PRODUCTS
Inquiry
Navs

Customer Review

Submit a review or a question

There are currently no Customer reviews or questions for AFC-TAB-424CQ. Click the button above to contact us or submit your feedback about this product.
Breast cancer biomarkers at key points during disease progression
User-friendly Preparation
Preparing Enoblituzumab for experiments was straightforward. Thawing on ice and gentle pipetting ensured the antibody's integrity, making our workflow efficient and error-free.
Breast cancer biomarkers at key points during disease progression
Superior ADCC Enhancement
Compared to other antibodies we've used, Enoblituzumab showed significantly enhanced ADCC activity. It's an excellent tool for functional assays where robust immune engagement is essential.
Breast cancer biomarkers at key points during disease progression
Highly Synergistic
When used alongside other therapeutic antibodies, Enoblituzumab exhibited strong synergistic effects, leading to improved antitumor responses in our combination therapy studies.

Q&As

  1. Is it possible to do research on ADCC processes in cancer cells with enutituzumab?

    A: Yes, Enoblituzumab is specifically designed to target CD276, which is overexpressed in various types of cancer cells, making it an ideal tool for studying Antibody-Dependent Cellular Cytotoxicity (ADCC) mechanisms in oncology research.

  2. How well does enotezumab conjugate when used in bioimaging investigations?

    A: Enoblituzumab can be conjugated with various fluorophores or enzymes suitable for immunofluorescence or immunohistochemistry applications, allowing for precise localization and quantification of CD276 expression.

  3. Is it possible to utilize enotuzumab in conjunction with other therapeutic antibodies to achieve synergistic effects?

    A: Yes, Enoblituzumab can be combined with other therapeutic antibodies that target distinct cancer markers, potentially leading to synergistic antitumor effects through combined mechanisms of action.

View the frequently asked questions answered by Creative Biolabs Support.

Cite This Product

To accurately reference this product in your publication, please use the following citation information:

(Creative Biolabs Cat# AFC-TAB-424CQ, RRID: AB_3111284)

Copy citation

Submit Your Publication

Published with our product? Submit your paper and receive a 10% discount on your next order! Share your research to earn exclusive rewards.

Article title:
DOI/PubMed URL:
Email:
Name:

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Biosimilar Overview

Please refer to Enoblituzumab Overview to learn more about the mechanism of action, clinical projects, and approved drugs of Enoblituzumab.

Downloadable Resources

Download resources about recombinant antibody development and antibody engineering to boost your research.

Product Notes

This is a product of Creative Biolabs' Hi-Affi™ recombinant antibody portfolio, which has several benefits including:

• Increased sensitivity
• Confirmed specificity
• High repeatability
• Excellent batch-to-batch consistency
• Sustainable supply
• Animal-free production

See more details about Hi-Affi™ recombinant antibody benefits.

Datasheet

MSDS

COA

Certificate of Analysis Lookup

To download a Certificate of Analysis, please enter a lot number in the search box below. Note: Certificate of Analysis not available for kit components.

Lot Number:

Protocol & Troubleshooting

We have outlined the assay protocols, covering reagents, solutions, procedures, and troubleshooting tips for common issues in order to better assist clients in conducting experiments with our products. View the full list of Protocol & Troubleshooting.

See other products for "CD276"

Select a product category from the dropdown menu below to view related products.

CAT Product Name Application Type
TAB-117CL Anti-Human CD276 Recombinant Antibody (TAB-117CL) ADCC, FuncS Antibody
TAB-424CQ Anti-Human CD276 Recombinant Antibody (TAB-424CQ) ELISA, IHC, FC, IP, IF, FuncS IgG1, κ
CAT Product Name Application Type
NEUT-333CQ Rat Anti-CD276 Recombinant Antibody (clone MJ18) Block, FC Rat IgG1
CAT Product Name Application Type
MOR-0549 Hi-Affi™ Rabbit Anti-CD276 Recombinant Antibody (clone DS549AB) WB, IP, FC Rabbit IgG
CAT Product Name Application Type
VS-0325-FY67 Human Anti-CD276 (clone MGA271) scFv-Fc Chimera ADCC Human IgG1, scFv-Fc
CAT Product Name Application Type
VS-0425-YC156 Recombinant Anti-CD276 Vesicular Antibody, EV Displayed (VS-0425-YC156) ELISA, FC, Cell-uptake
Specific Inquiry
Go to compare Add to compare

For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.

Send Inquiry

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Go to compare

Go to compare